StockWatch: Analysts Weigh Obesity Drug Market Pegged at $100B by 2030 genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson s Disease streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
- ATH434 improved motor performance and general function – - Webcast to be held this week to discuss new data and recent clinical progress – MELBOURNE, Australia and SAN FRANCISCO, Dec. 04,.
Alterity Therapeutics Inc (NASDAQ: ATHE) shares are trading higher after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's